Daniel Maurus

Statistics

Publications

Citations

5.6K

H-Index

Active since

2013

Affiliations

University Medical Center of the Johannes Gutenberg University Mainz(Current)

Johannes Gutenberg University Mainz

BioNTech (Germany)

Pfizer (United States)

University Hospital Heidelberg

Daniel Maurus is an author at University Medical Center of the Johannes Gutenberg University Mainz specializing in oncology, immunology, and medicine.

ORCID

Publications per year

2013–2025

Publications

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Uğur Şahin, Petra Oehm, Evelyna Derhovanessian et al. · Nature · 2020 · 1K citations

Medicine, Immunology, Oncology +14

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Uğur Şahin, Alexander Muik, Isabel Vogler et al. · Nature · 2021 · 833 citations · Full text

Life Sciences, Immunology, Immunization +10

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

Alexander Muik, Ann-Kathrin Wallisch, Bianca Sänger et al. · Science · 2021 · 556 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

Uğur Şahin, Ö. Türeci, Georgy M. Manikhas et al. · Annals of Oncology · 2021 · 359 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 17